Shaaban AE, Jourdain H, Desplas D, Vignot S, et al. Real-world use and survival outcomes of sacituzumab govitecan in metastatic triple-negative breast cancer and hormone receptor-positive/HER2-negative metastatic breast cancer. Br J Cancer 2026 Feb 5. doi: 10.1038/s41416-026-03346.
PMID: 41644812